Skip to main content

Erratum to: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life

Correction

Following the publication of our article [1], we noticed an error regarding the dosage of vitamin B12. In the manuscript, we reported that the daily dosage of vitamin B12 would be 0.4 mg, when in fact the dosage of vitamin B12 used in the B-VITAGE trial is 0.5 mg per day.

In the abstract:

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.4 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

Should read

The B-VITAGE trial is a 12-month randomized, double-blind, placebo-controlled trial of daily citalopram (20 to 40 mg) plus B12(0.5 mg), B6 (25 mg) and folic acid (2 mg) or citalopram (20 to 40 mg) plus placebo for the treatment of depression in later life.

In the "Intervention and Blinding" section:

Eligible participants will be randomly allocated to treatment with citalopram plus 400 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

Should read

Eligible participants will be randomly allocated to treatment with citalopram plus 500 μg vitamin B12, 2 mg folic acid and 25 mg B6 or citalopram plus placebo.

References

  1. 1.

    Ford AH, Flicker L, McCaul K, van Bockxmeer F, Hegarty S, Hirani V, Fenner S, Almeida OP: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials. 2010, 11: 8-10.1186/1745-6215-11-8.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Osvaldo P Almeida.

Additional information

The online version of the original article can be found at 10.1186/1745-6215-11-8

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ford, A.H., Flicker, L., McCaul, K. et al. Erratum to: The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life. Trials 12, 193 (2011). https://0-doi-org.brum.beds.ac.uk/10.1186/1745-6215-12-193

Download citation